Basta Steven L

Director at BIOFORM MEDICAL INC · on record since Nov 5, 2007
Chief Executive Officer at BIOFORM MEDICAL INC · on record since Nov 5, 2007
10% owner at BIOFORM MEDICAL INC · on record since Nov 5, 2007
Director at Phathom Pharmaceuticals, Inc. · on record since Apr 3, 2025
President and CEO at Phathom Pharmaceuticals, Inc. · on record since Apr 3, 2025
Director at KalVista Pharmaceuticals, Inc. · on record since Apr 8, 2015
Director at VYNE Therapeutics Inc. · on record since Jan 24, 2018
Director at PLC SYSTEMS INC · on record since Sep 14, 2018
Chief Executive Officer at VYNE Therapeutics Inc. · on record since Jan 24, 2018

Insider trading activity of Basta Steven L

Transactions on record: 73; since Jul 11, 2008

Open-market buys: 0

Open-market sells: 1; $81.8K

Companies traded: 5; last filing Feb 12, 2026

Figures computed from official regulatory filings — methodology.

Companies where Basta Steven L has traded

Phathom Pharmaceuticals, Inc.14 tx · $1.9M · Feb 12, 2026
VYNE Therapeutics Inc.24 tx · $872.8K · Dec 15, 2025
PLC SYSTEMS INC11 tx · $39.5 · Jan 5, 2023
KalVista Pharmaceuticals, Inc.5 tx · $18.5K · Nov 22, 2016
BIOFORM MEDICAL INC19 tx · $5.3M · Feb 19, 2010

Track record of Basta Steven L

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Basta Steven L

Co-insiders of Basta Steven L

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Phathom Pharmaceuticals, Inc.	Feb 12, 2026	Award	12,362	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Feb 12, 2026	Other	-6,277	12.82 USD	$80.5K	SEC
Phathom Pharmaceuticals, Inc.	Jan 2, 2026	Award	251,034	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Jan 2, 2026	AwardD	226,156	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Dec 19, 2025	Other	-31,502	15.36 USD	$483.9K	SEC
Phathom Pharmaceuticals, Inc.	Dec 19, 2025	Award	62,038	0.00 USD	$0	SEC
VYNE Therapeutics Inc.	Dec 15, 2025	AwardD	20,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Dec 2, 2025	Exercise	90,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Dec 2, 2025	Other	-48,375	15.62 USD	$755.6K	SEC
Phathom Pharmaceuticals, Inc.	Dec 2, 2025	ExerciseD	-90,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Sep 26, 2025	Exercise	90,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Sep 26, 2025	ExerciseD	-90,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Sep 26, 2025	Other	-48,375	11.66 USD	$564.1K	SEC
Phathom Pharmaceuticals, Inc.	Apr 3, 2025	AwardD	1,085,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Apr 3, 2025	AwardD	360,000	0.00 USD	$0	SEC
VYNE Therapeutics Inc.	Dec 13, 2024	AwardD	20,000	0.00 USD	$0	SEC
VYNE Therapeutics Inc.	Jan 3, 2024	AwardD	20,000	0.00 USD	$0	SEC
VYNE Therapeutics Inc.	Dec 15, 2023	AwardD	20,000	0.00 USD	$0	SEC
PLC SYSTEMS INC	Jan 5, 2023	AwardD	72,000	0.00 USD	$0	SEC
VYNE Therapeutics Inc.	Aug 12, 2022	AwardD	20,500	0.00 USD	$0	SEC
PLC SYSTEMS INC	Jan 6, 2022	AwardD	48,000	0.00 USD	$0	SEC
PLC SYSTEMS INC	Dec 17, 2021	Other	-28	1.41 USD	$39.5	SEC
VYNE Therapeutics Inc.	Jul 20, 2021	AwardD	20,500	0.00 USD	$0	SEC
PLC SYSTEMS INC	Jun 25, 2021	AwardD	116,200	0.00 USD	$0	SEC
PLC SYSTEMS INC	Jan 22, 2021	AwardD	50,000	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Phathom Pharmaceuticals, Inc.	Feb 12, 2026	Award	12,362	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Feb 12, 2026	Other	-6,277	12.82 USD	$80.5K	SEC
Phathom Pharmaceuticals, Inc.	Jan 2, 2026	Award	251,034	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Jan 2, 2026	AwardD	226,156	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Dec 19, 2025	Other	-31,502	15.36 USD	$483.9K	SEC
Phathom Pharmaceuticals, Inc.	Dec 19, 2025	Award	62,038	0.00 USD	$0	SEC
VYNE Therapeutics Inc.	Dec 15, 2025	AwardD	20,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Dec 2, 2025	Exercise	90,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Dec 2, 2025	Other	-48,375	15.62 USD	$755.6K	SEC
Phathom Pharmaceuticals, Inc.	Dec 2, 2025	ExerciseD	-90,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Sep 26, 2025	Exercise	90,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Sep 26, 2025	ExerciseD	-90,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Sep 26, 2025	Other	-48,375	11.66 USD	$564.1K	SEC
Phathom Pharmaceuticals, Inc.	Apr 3, 2025	AwardD	1,085,000	0.00 USD	$0	SEC
Phathom Pharmaceuticals, Inc.	Apr 3, 2025	AwardD	360,000	0.00 USD	$0	SEC
VYNE Therapeutics Inc.	Dec 13, 2024	AwardD	20,000	0.00 USD	$0	SEC
VYNE Therapeutics Inc.	Jan 3, 2024	AwardD	20,000	0.00 USD	$0	SEC
VYNE Therapeutics Inc.	Dec 15, 2023	AwardD	20,000	0.00 USD	$0	SEC
PLC SYSTEMS INC	Jan 5, 2023	AwardD	72,000	0.00 USD	$0	SEC
VYNE Therapeutics Inc.	Aug 12, 2022	AwardD	20,500	0.00 USD	$0	SEC
PLC SYSTEMS INC	Jan 6, 2022	AwardD	48,000	0.00 USD	$0	SEC
PLC SYSTEMS INC	Dec 17, 2021	Other	-28	1.41 USD	$39.5	SEC
VYNE Therapeutics Inc.	Jul 20, 2021	AwardD	20,500	0.00 USD	$0	SEC
PLC SYSTEMS INC	Jun 25, 2021	AwardD	116,200	0.00 USD	$0	SEC
PLC SYSTEMS INC	Jan 22, 2021	AwardD	50,000	0.00 USD	$0	SEC